These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 12544532
81. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report. Li Y, Han Z, Wang X, Mo Z, Zhang W, Li A, Liu S. BMC Gastroenterol; 2013 Dec 09; 13():167. PubMed ID: 24321021 [Abstract] [Full Text] [Related]
82. Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement. Donghi D, Mainetti C. Dermatology; 2010 Dec 09; 220(3):282-6. PubMed ID: 20110641 [No Abstract] [Full Text] [Related]
83. [Echocardiographic evaluation of anti-tumor necrosis factor-alpha therapy with infliximab in patients without cardiac pathologies]. Bragagni G, Lari F, Magenta G, Brogna R, Zoli G. Recenti Prog Med; 2010 Dec 09; 101(7-8):289-92. PubMed ID: 20842955 [Abstract] [Full Text] [Related]
84. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease. Takeuchi M, Asukata Y, Kawagoe T, Ito N, Nishide T, Mizuki N. Ocul Immunol Inflamm; 2012 Jun 09; 20(3):193-7. PubMed ID: 22486264 [Abstract] [Full Text] [Related]
85. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab. Coulter I, Huda S, Baborie A, Jacob A. J Spinal Cord Med; 2012 Mar 09; 35(2):122-4. PubMed ID: 22333754 [Abstract] [Full Text] [Related]
86. Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report. Tolosa-Vilella C, Capela CA, Monteagudo-Jiménez M, Marí-Alfonso B. Clin Exp Rheumatol; 2011 Mar 09; 29(4 Suppl 67):S94-5. PubMed ID: 21385550 [No Abstract] [Full Text] [Related]
87. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Lancet; 2001 Jul 28; 358(9278):295-6. PubMed ID: 11498218 [Abstract] [Full Text] [Related]
88. Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease. Ribi C, Sztajzel R, Delavelle J, Chizzolini C. J Neurol Neurosurg Psychiatry; 2005 Dec 28; 76(12):1733-5. PubMed ID: 16291906 [Abstract] [Full Text] [Related]
89. Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients. Katsiari CG, Theodossiadis PG, Kaklamanis PG, Markomichelakis NN, Sfikakis PP. Adv Exp Med Biol; 2003 Dec 28; 528():551-5. PubMed ID: 12918762 [No Abstract] [Full Text] [Related]
97. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Pipitone N, Olivieri I, Padula A, D'angelo S, Nigro A, Zuccoli G, Boiardi L, Salvarani C. Arthritis Rheum; 2008 Feb 15; 59(2):285-90. PubMed ID: 18240181 [No Abstract] [Full Text] [Related]